ShareCast News for Animalcare Grp (ANCR)
Mon, 5th Oct 2009 08:53
Veterinary and farming supplies company Animalcare revealed a modest rise in annual pre-tax profit, in line with company expectations, driven by growth in veterinary medicines across the year.
Profit before tax rose to £1.53m for the year ended 30 June 2009 from £1.11m the year before. Revenue increased to £17.64m during the period from £11.76m before.
"The granting and exploitation of regulatory approvals for licensed veterinary medicines has been the main engine of growth across the business during the financial year," Animalcare explained.
"The company is implementing plans to deliver organic growth from all areas of the business across markets that are either stable or growing," the group added.
The board is recommending a dividend of 2.5p an increase of 11.1% over the previous financial year.
A round-up of the biggest director buys today so far.
[5 Apr '13]Animalcare, a veterninary products group, has produced an anaemic set of full-year results with both turnover and profits below last year's levels.
[4 Oct '12]Also covered by this round-up are: Porvair, Oxford Pharmascience, Planet Payment, Hydro International, and International Greetings.
[24 May '12]Animalcare Group, a supplier of veterinary medicines, has said that its Project Quatto has received marketing authorisation from the Veterinary Medicines Directorate. The firm can now place the product on the market. The first sales are expected by the end of the current financial year.
[23 Mar '12]JP Morgan Russian Securities is trading at a discount to its net asset value of 727.53p as of March 15. It holds at 13.3% stake in Sberbank of Russia, 9.4% of retailer Magnit and 6.9% of miner Norilsk Nickel. Its largest investments are in the consumer staples, minerals and financial sectors.
[20 Mar '11]Pet medicines supplier Animalcare has sold its non-core livestock products business and this has removed the seasonality of the group's revenues.
[17 Feb '11]Veterinary medicines supplier Animalcare says its core operations grew revenues by 10% in the six months to December 2010.
[20 Jan '11]Animalcare has completed the sale and closure of its livestock products businesses and it will focus on its pet treatments business from now on.
[4 Oct '10]